A pilot study of Pemetrexed, Platinum agent plus Bevacizumab for advanced non-squamous non-small cell lung cancer with brain metastases
Not Applicable
- Conditions
- Advanced non-squamous NSCLC
- Registration Number
- JPRN-UMIN000011615
- Lead Sponsor
- Yokohama Rosai Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1. symptomatic brain metastasis 2. history or complication of hemoptysis. 3. history of severe drug allergy 4. uncontrolled ascites, pleural effusion, or pericardial effusion 5. history of gastrointestinal perforation within one year, or a complication 6. uncontrolled hypertension 7. active infection requiring systemic administration of antiviral agents, antifungal agents, or antibiotics 8. antipletet therapy for chronic disease 9. irradiation to the chest or more than 20% region of bones 10. multiple cancer within 5 years 11. serious complications 12. pregnancy or lactation 13. inappropriate for this study judged by the attending physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method